Analysis of a gene co-expression network establishes robust association between Col5a2 and ischemic heart disease

BMC Medical Genomics

Daniel R Wagner⁴  Sophie Rodius¹  Sarah-Lena Puhl²  Céline Jeanty¹  Lu Zhang³  Francisco Azuaje¹ 

[1] Current Address: Department of Oncology, NorLux Neuro-Oncology Laboratory, CRP-Santé, Luxembourg, Luxembourg;Department of Internal Medicine III, Saarland University Hospital, Homburg, Germany;Department of Translational Cardiovascular Research, CRP-Santé, Luxembourg, Luxembourg;Division of Cardiology, Centre Hospitalier, Luxembourg, Luxembourg

关键词: Col5a2;    Collagen proteins;    Myocardial infarction;    Co-expression networks;    Systems-based approaches;   

Others  :  1092485
DOI  :  10.1186/1755-8794-6-13

 received in 2012-10-12, accepted in 2013-03-26,  发布年份 2013

【 摘 要 】

Background

This study aims to expand knowledge of the complex process of myocardial infarction (MI) through the application of a systems-based approach.

Methods

We generated a gene co-expression network from microarray data originating from a mouse model of MI. We characterized it on the basis of connectivity patterns and independent biological information. The potential clinical novelty and relevance of top predictions were assessed in the context of disease classification models. Models were validated using independent gene expression data from mouse and human samples.

Results

The gene co-expression network consisted of 178 genes and 7298 associations. The network was dissected into statistically and biologically meaningful communities of highly interconnected and co-expressed genes. Among the most significant communities, one was distinctly associated with molecular events underlying heart repair after MI (P < 0.05). Col5a2, a gene previously not specifically linked to MI response but responsible for the classic type of Ehlers-Danlos syndrome, was found to have many and strong co-expression associations within this community (11 connections with ρ > 0.85). To validate the potential clinical application of this discovery, we tested its disease discriminatory capacity on independently generated MI datasets from mice and humans. High classification accuracy and concordance was achieved across these evaluations with areas under the receiving operating characteristic curve above 0.8.

Conclusion

Network-based approaches can enable the discovery of clinically-interesting predictive insights that are accurate and robust. Col5a2 shows predictive potential in MI, and in principle may represent a novel candidate marker for the identification and treatment of ischemic cardiovascular disease.

【 授权许可】

   
2013 Azuaje et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Nabel EG, Braunwald E: A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012, 366:54-63.
• [2]Ertl G, Frantz S: Healing after myocardial infarction. Cardiovasc Res 2005, 66:22-32.
• [3]Fraccarollo D, Galuppo P, Bauersachs J: Novel therapeutic approaches to post-infarction remodelling. Cardiovasc Res 2012, 94:293-303.
• [4]Schadt EE: Molecular networks as sensors and drivers of common human diseases. Nature 2009, 461:218-223.
• [5]Vidal M, Cusick ME, Barabasi AL: Interactome networks and human disease. Cell 2011, 144:986-998.
• [6]Azuaje F, Devaux Y, Wagner DR: Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network. BMC Syst Biol 2010, 4:60. BioMed Central Full Text
• [7]Azuaje FJ, Dewey FE, Brutsaert DL, Devaux Y, Ashley EA, Wagner DR: Systems-based approaches to cardiovascular biomarker discovery. Circ Cardiovasc Genet 2012, 5:360-367.
• [8]Dewey FE, Perez MV, Wheeler MT, Watt C, Spin J, Langfelder P, Horvath S, Hannenhalli S, Cappola TP, Ashley EA: Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circ Cardiovasc Genet 2011, 4:26-35.
• [9]Dewey FE, Wheeler MT, Ashley EA: Systems biology of heart failure, challenges and hopes. Curr Opin Cardiol 2011, 26:314-321.
• [10]Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S: Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 2004, 16:349-360.
• [11]Harpster MH, Bandyopadhyay S, Thomas DP, Ivanov PS, Keele JA, Pineguina N, Gao B, Amarendran V, Gomelsky M, McCormick RJ, Stayton MM: Earliest changes in the left ventricular transcriptome postmyocardial infarction. Mamm Genome 2006, 17:701-715.
• [12]Allen P, Bartunek J, Maddi R, Mitchell R, De Bruyne B, Goethals M: Human Cardiac Tissues, Control and Diseased. 2004. http://cardiogenomics.med.harvard.edu/project-detail?project_id=229 webcite
• [13]BLAST: Basic Local Alignment Search Tool. http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi webcite
• [14]Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT: The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
• [15]Tarraga J, Medina I, Carbonell J, Huerta-Cepas J, Minguez P, Alloza E, Al-Shahrour F, Vegas-Azcarate S, Goetz S, Escobar P, Garcia-Garcia F, Conesa A, Montaner D, Dopazo J: GEPAS, a web-based tool for microarray data analysis and interpretation. Nucleic Acids Res 2008, 36:W308-314.
• [16]Gautier L, Cope L, Bolstad BM, Irizarry RA: affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20:307-315.
• [17]Enright AJ, Ouzounis CA: BioLayout–an automatic graph layout algorithm for similarity visualization. Bioinformatics 2001, 17:853-854.
• [18]Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27:431-432.
• [19]da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
• [20]Witten IH, Frank E: Data mining: practical machine learning tools and techniques. 2nd edition. San Francisco: Elsevier, Inc; 2005.
• [21]SystatSoftware: SigmaPlot statistics user’s guide. San Jose: Systat Software, Inc; 2008.
• [22]Romanoski CE, Che N, Yin F, Mai N, Pouldar D, Civelek M, Pan C, Lee S, Vakili L, Yang WP, Kayne P, Mungrue IN, Araujo JA, Berliner JA, Lusis AJ: Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res 2011, 109:e27-41.
• [23]Chen J, Sam L, Huang Y, Lee Y, Li J, Liu Y, Xing HR, Lussier YA: Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures. J Biomed Inform 2010, 43:385-396.
• [24]Dudley JT, Tibshirani R, Deshpande T, Butte AJ: Disease signatures are robust across tissues and experiments. Mol Syst Biol 2009, 5:307.
• [25]Cleutjens JP, Creemers EE: Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction. J Card Fail 2002, 8:S344-348.
• [26]Bashey RI, Donnelly M, Insinga F, Jimenez SA: Growth properties and biochemical characterization of collagens synthesized by adult rat heart fibroblasts in culture. J Mol Cell Cardiol 1992, 24:691-700.
• [27]Jane-Lise S, Corda S, Chassagne C, Rappaport L: The extracellular matrix and the cytoskeleton in heart hypertrophy and failure. Heart Fail Rev 2000, 5:239-250.
• [28]Lincoln J, Florer JB, Deutsch GH, Wenstrup RJ, Yutzey KE: ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. Dev Dyn 2006, 235:3295-3305.
• [29]Birk DE: Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001, 32:223-237.
• [30]Kadler KE, Hill A, Canty-Laird EG: Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 2008, 20:495-501.
• [31]Andrikopoulos K, Suzuki HR, Solursh M, Ramirez F: Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. Dev Dyn 1992, 195:113-120.
• [32]Andrikopoulos K, Liu X, Keene DR, Jaenisch R, Ramirez F: Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet 1995, 9:31-36.
• [33]Tan G, Shim W, Gu Y, Qian L, Chung YY, Lim SY, Yong P, Sim E, Wong P: Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells. Differentiation 2010, 79:260-271.
• [34]Cole WG, Chan D, Hickey AJ, Wilcken DE: Collagen composition of normal and myxomatous human mitral heart valves. Biochem J 1984, 219:451-460.
• [35]Peacock JD, Lu Y, Koch M, Kadler KE, Lincoln J: Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance. Dev Dyn 2008, 237:3051-3058.
• [36]Malfait F, Wenstrup RJ, De Paepe A: Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 2010, 12:597-605.
• [37]Grond-Ginsbach C, Chen B, Pjontek R, Wiest T, Jiang Y, Burwinkel B, Tchatchou S, Krawczak M, Schreiber S, Brandt T, Kloss M, Arnold ML, Hemminki K, Lichy C, Lyrer PA, Hausser I, Engelter ST: Copy number variation in patients with cervical artery dissection. Eur J Hum Genet 2012, 20:1295-1299.
• [38]Meienberg J, Rohrbach M, Neuenschwander S, Spanaus K, Giunta C, Alonso S, Arnold E, Henggeler C, Regenass S, Patrignani A, Azzarello-Burri S, Steiner B, Nygren AO, Carrel T, Steinmann B, Matyas G: Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency. Eur J Hum Genet 2010, 18:1315-1321.
• [39]Vargas AC, Reed AE, Waddell N, Lane A, Reid LE, Smart CE, Cocciardi S, da Silva L, Song S, Chenevix-Trench G, Simpson PT, Lakhani SR: Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat 2012, 135:153-165.
• [40]Fischer H, Stenling R, Rubio C, Lindblom A: Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis 2001, 22:875-878.
• [41]Xi L, Lyons-Weiler J, Coello MC, Huang X, Gooding WE, Luketich JD, Godfrey TE: Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res 2005, 11:4128-4135.
• [42]Lu P, Zhang GR, Song XH, Zou XH, Wang LL, Ouyang HW: Col V siRNA engineered tenocytes for tendon tissue engineering. PLoS One 2011, 6:e21154.
• [43]Chanut-Delalande H, Bonod-Bidaud C, Cogne S, Malbouyres M, Ramirez F, Fichard A, Ruggiero F: Development of a functional skin matrix requires deposition of collagen V heterotrimers. Mol Cell Biol 2004, 24:6049-6057.